In October 1998, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and the Wellcome Trust, launched the Roll Back Malaria Global Partnership. Hosted by a WHO Secretariat, it aims to provide global leadership, strategy, and overall coordinating mechanisms to reduce the global malaria burden by 50% by the year 2010 through interventions adapted to local needs and strengthening of the health sector. RBM seeks to strengthen health systems to ensure better delivery of health care, especially at district and community levels; ensure the proper and expanded use of insecticide-treated mosquito nets; ensure adequate access to basic healthcare and training of healthcare workers; encourage the development of simpler and more effective means of administering medicines, such as training of village health workers, mothers and drug sellers on early and appropriate treatment of malaria, especially for children; encourage the development of more effective and new anti-malaria drugs and vaccines.